These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 15100679

  • 1. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers.
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [Abstract] [Full Text] [Related]

  • 2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 4. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium.
    Arch Intern Med; 2008 Dec 08; 168(22):2405-14. PubMed ID: 19064822
    [Abstract] [Full Text] [Related]

  • 5. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD, GRC28 Study Team.
    Pediatr Infect Dis J; 2010 Feb 08; 29(2):105-10. PubMed ID: 19934787
    [Abstract] [Full Text] [Related]

  • 6. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003 Feb 08; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

  • 7. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T, Arnoux S, Kobryn A, Gorski P.
    J Asthma; 2007 Dec 08; 44(10):817-22. PubMed ID: 18097856
    [Abstract] [Full Text] [Related]

  • 8. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN.
    Clin Gastroenterol Hepatol; 2007 Jul 08; 5(7):851-6. PubMed ID: 17544875
    [Abstract] [Full Text] [Related]

  • 9. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB, Romanowska M, Nowak I, Ciszewski A, Bilińska ZT.
    Med Sci Monit; 2009 Jul 08; 15(7):PH85-91. PubMed ID: 19564837
    [Abstract] [Full Text] [Related]

  • 10. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy.
    Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD.
    Pediatrics; 1996 Aug 08; 98(2 Pt 1):196-200. PubMed ID: 8692617
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M.
    N Engl J Med; 2006 Mar 30; 354(13):1343-51. PubMed ID: 16571878
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.
    Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 02; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
    Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D.
    J Infect Dis; 2006 Oct 15; 194(8):1032-9. PubMed ID: 16991077
    [Abstract] [Full Text] [Related]

  • 15. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.
    Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.
    J Infect Dis; 2008 Sep 01; 198(5):635-41. PubMed ID: 18694338
    [Abstract] [Full Text] [Related]

  • 16. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 01; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 17. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 18. Immune response to influenza vaccine in adult liver transplant recipients.
    Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ.
    Liver Transpl; 2001 Apr 27; 7(4):311-3. PubMed ID: 11303290
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL, Toback SL, Yi T, Ambrose CS.
    Clin Ther; 2009 Oct 27; 31(10):2140-7. PubMed ID: 19922885
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.
    Clin Ther; 2007 Aug 27; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.